Parallel Advisors’s Blueprint Medicines BPMC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-275
| Closed | -$35.3K | – | 3568 |
|
|
2025
Q2 | $35.3K | Hold |
275
| – | – | ﹤0.01% | 1911 |
|
|
2025
Q1 | $24.3K | Sell |
275
-29
| -10% | -$2.83K | ﹤0.01% | 2034 |
|
|
2024
Q4 | $26.5K | Buy |
304
+18
| +6% | +$1.65K | ﹤0.01% | 2007 |
|
|
2024
Q3 | $26.5K | Buy |
286
+27
| +10% | +$2.68K | ﹤0.01% | 1938 |
|
|
2024
Q2 | $27.9K | Sell |
259
-17
| -6% | -$1.7K | ﹤0.01% | 1806 |
|
|
2024
Q1 | $26.2K | Buy |
276
+28
| +11% | +$2.4K | ﹤0.01% | 1832 |
|
|
2023
Q4 | $22.9K | Buy |
248
+118
| +91% | +$7.65K | ﹤0.01% | 1849 |
|
|
2023
Q3 | $6.53K | Buy |
130
+121
| +1,344% | +$6.47K | ﹤0.01% | 2389 |
|
|
2023
Q2 | $569 | Hold |
9
| – | – | ﹤0.01% | 3072 |
|
|
2023
Q1 | $405 | Buy |
+9
| New | +$405 | ﹤0.01% | 3166 |
|
|
2022
Q4 | – | Sell |
-6
| Closed | – | – | 3367 |
|
|
2022
Q3 | $0 | Buy |
+6
| New | +$385 | ﹤0.01% | 3157 |
|
|
2022
Q2 | – | Sell |
-21
| Closed | -$1K | – | 3015 |
|
|
2022
Q1 | $1K | Sell |
21
-127
| -86% | -$9.12K | ﹤0.01% | 2702 |
|
|
2021
Q4 | $16K | Sell |
148
-2
| -1% | -$209 | ﹤0.01% | 1883 |
|
|
2021
Q3 | $15K | Buy |
150
+129
| +614% | +$12K | ﹤0.01% | 1865 |
|
|
2021
Q2 | $2K | Sell |
21
-11
| -34% | -$1.01K | ﹤0.01% | 2531 |
|
|
2021
Q1 | $3K | Buy |
32
+11
| +52% | +$1.1K | ﹤0.01% | 2342 |
|
|
2020
Q4 | $2K | Hold |
21
| – | – | ﹤0.01% | 2274 |
|
|
2020
Q3 | $2K | Hold |
21
| – | – | ﹤0.01% | 2273 |
|
|
2020
Q2 | $1K | Sell |
21
-13
| -38% | -$879 | ﹤0.01% | 2292 |
|
|
2020
Q1 | $1K | Buy |
34
+12
| +55% | +$772 | ﹤0.01% | 2238 |
|
|
2019
Q4 | $2K | Hold |
22
| – | – | ﹤0.01% | 2177 |
|
|
2019
Q3 | $2K | Hold |
22
| – | – | ﹤0.01% | 2144 |
|
|
2019
Q2 | $2K | Buy |
+22
| New | +$1.82K | ﹤0.01% | 2059 |
|
|
2018
Q3 | – | Sell |
-16
| Closed | -$1K | – | 2223 |
|
|
2018
Q2 | $1K | Buy |
+16
| New | +$1.27K | ﹤0.01% | 1956 |
|
Other funds holding BPMC
IA
HNB
Parallel Advisors's BPMC Position: Q3 2025 in Review
Parallel Advisors sold out of Blueprint Medicines (BPMC) in Q3 2025, closing a stake of 275 shares — an estimated $35.3K sold.
Parallel Advisors first reported a position in BPMC in Q2 2018 and held it in 24 quarters. The position peaked at $35.3K in Q2 2025. 5 funds tracked by Wall St. Rank hold BPMC as of Q3 2025.
- Parallel Advisors reported no remaining Blueprint Medicines position as of Q3 2025 after selling out during the quarter.
- Parallel Advisors sold 275 Blueprint Medicines shares in Q3 2025, an estimated $35.3K.
- Parallel Advisors first reported a position in Blueprint Medicines in Q2 2018 and held it in 24 quarters.
- Parallel Advisors's Blueprint Medicines position peaked at $35.3K in Q2 2025.
- 5 funds tracked by Wall St. Rank held Blueprint Medicines as of Q3 2025.
Based on Parallel Advisors's 13F filing for Q3 2025, filed 13 Nov 2025.